System for size based separation and analysis
The invention relates to one or more size-based separation modules adapted to increase a concentration of a first analyte in a sample by at least 10,000 fold, wherein said first analyte has an initial concentration in said sample of less than 1×10 −3 analytes/μL, and an analyzer for analyzing said first analytes in an enriched medium.
1 . A system comprising:
one or more size-based separation modules adapted to increase a concentration of a first analyte in a sample by at least 10,000 fold, wherein said first analyte has an initial concentration in said sample of less than 1×10 −3 analytes/μL, and
an analyzer comprising computer executable logic for analyzing said first analytes in an enriched medium.
2 . The system of claim 1 wherein said analyzer further comprises a microscope, a microarray, or cell counter.
3 . The system of claim 1 wherein said computer executable logic detects a color change in the presence of fetal hemoglobin, globin γ, globin ε, GPA, i-antigen, CD36, selectins, CD71 or a combination thereof.
4 . The system of claim 1 wherein said computer executable logic detects intensities of probes that selectively bind said first analytes.
5 . The system of claim 1 wherein said computer executable logic performs three-dimensional image analysis of said first analytes.
6 . The system of claim 1 wherein said analyzer has dual scanning capabilities.
7 . The system of claim 1 wherein said computer executable logic images said first analytes.
8 . The system of claim 1 wherein said computer executable logic determines trisomy, sex of a fetus, or chromosomal abnormalities in a cell of interest.
9 . The system of claim 1 wherein each of said size-based separation modules comprises a two-dimensional array of obstacles that direct said first analyte deterministically in a first direction and a second analyte having a hydrodynamic size smaller than said first analyte in a second direction.
10 . The system of claim 9 wherein said first analyte is a nucleated red blood cell.
11 . The system of claim 9 wherein said first analyte is a fetal nucleated red blood cell.
12 . The system of claim 1 wherein said system comprises two or more size-based separation modules fluidly coupled in parallel with one another.
13 . The system of claim 1 adapted for high-throughput analysis of at least 10 mL of said fluid sample per hour.
14 . The system of claim 1 further comprising one or more capture modules fluidly coupled to said size-based separation modules, wherein said capture modules selectively capture said first analyte or a second analyte from said sample.
15 . The system of claim 14 wherein each of said capture modules comprises a two-dimensional array of obstacles.
16 . The system of claim 14 wherein each of said capture modules comprises a two-dimensional array of obstacles coupled to one or more antibodies.
17 . The system of claim 16 wherein said antibodies selectively bind a red blood cell, a white blood cell, a fetal blood cell, a fetal nucleated blood cell, a cancer cell, an epithelial cell, or stem cell, a progenitor cell, a foam cell, or a platelet.
18 . The system of claim 16 wherein said antibodies are selected from the group consisting of: anti-CD71, anti-CD36, anti-CD451, anti-GPA, anti-selectin, anti-carbohydrates, anti-antigen-i, and anti-EpCaM.
19 . The system of claim 1 wherein said fluid sample is a blood sample and said first analyte is selected from the group consisting of: an epithelial cell, an endothelial cell, a progenitor cell, a stem cell, a foam cell, or a cancer cell.
20 . The system of claim 1 wherein said fluid sample is a blood sample and is less than 5 mL.
21 . The system of claim 1 wherein said fluid sample is a blood sample derived from a female who is in less than 12 weeks of gestation.
22 . The system of claim 1 wherein gap between obstacles in said separation regions is less than 1000 microns.
23 . The system of claim 1 further comprising a reservoir containing magnetic particles fluidly coupled to said separation region or said capture regions.
24 . The system of claim 1 wherein said system further comprises magnetic beads adapted to preferentially bind to said first analyte or said second analyte.
25 . The system of claim 24 wherein said magnetic beads are coupled to an antibody that specifically binds said first analyte.
26 . The system of claim 1 further comprising a reservoir fluidly coupled to said size-based separation module, wherein said reservoir contains magnetic particles adapted to preferentially bind said first analyte.
27 . The system of claim 2 wherein said analyzer comprises a microarray adapted to detect one or more SNPs in said first analyte.
28 . The system of claim 2 wherein said analyzer comprises a microarray adapted to detect levels of mRNA in said first analyte.
29 . The system of claim 9 wherein said obstacles are separated by gaps which direct the flow of sample unequally into subsequent gaps.